58
Views
2
CrossRef citations to date
0
Altmetric
Letter to the Editor

Autoimmune paraneoplastic cerebellar degeneration secondary to a composite lymphoma

, &
Pages 1456-1458 | Received 23 Mar 2007, Accepted 06 Apr 2007, Published online: 01 Jul 2009

References

  • Cavalli F. Rare syndromes in Hodgkin's disease. Ann Oncol 1998; 9(Suppl 5)S109–S113
  • Martinez A, Aymerich M, Castillo M, Colomer D, Bellosillo B, Campo E, et al. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. Cytometry B Clin Cytom 2003; 56: 8–15
  • Shams'ili S, Grefkens J, de Leeuw B, van den Bent M, Hooijkaas H, van der Holt B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: Analysis of 50 patients. Brain 2003; 126: 1409–1418
  • Graus F, Delattre J Y, Antoine J C, Dalmau J, Giometto B, Grisold W, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry 2004; 75: 1135–1140
  • Bernal F, Shams'ili S, Rojas I, Sanchez-Valle R, Saiz A, Dalmau J, et al. Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin's disease. Neurology 2003; 60: 230–234
  • Ypma P F, Wijermans P W, Koppen H, Sillevis Smitt P A. Paraneoplastic cerebellar degeneration preceding the diagnosis of Hodgkin's lymphoma. Neth J Med 2006; 64: 243–247
  • Graus F, Gultekin S H, Ferrer I, Reiriz J, Alberch J, Dalmau J. Localization of the neuronal antigen recognized by anti-Tr antibodies from patients with paraneoplastic cerebellar degeneration and Hodgkin's disease in the rat nervous system. Acta Neuropathol (Berl) 1998; 96: 1–7
  • Taniguchi Y, Tanji C, Kawai T, Saito H, Marubayashi S, Yorioka N. A case report of plasmapheresis in paraneoplastic cerebellar ataxia associated with anti-Tr antibody. Ther Apher Dial 2006; 10: 90–93
  • Cramer S C, Glaspy J A, Efird J T, Louis D N. Chronic lymphocytic leukemia and the central nervous system: A clinical and pathological study. Neurology 1996; 46: 19–25

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.